Thursday, April 11, 2024 2:45:14 PM
My issue is Foley was 100% in charge and owns the premium price strategy and also owns the fact that he waisted $300 million plus! He is the captain who has kicked everyone else off the boat he was driving and blames everyone else! He has never been a real leader and taken ownership!
I have watched all his videos and messages! Secondly, if you follow Mertz, Allergan or Evolus, their teams communicate weekly through Instagram and LinkedIn commentary on advancements with products and industry support! Foley or his team (which he may have fired everyone) has not provided a positive communication to investors or the general public since he did the last investor interview. All he discussed is how he is fixing the company..not his mistakes. He could announce the new lip indication for RHA3, he could announce their new VP of Sales who is doing…….to build and grow the RVNC culture, he could announce Dr Leed and all the Daxi trainers who are available to assist all and any practices with training and learning, he could announced the support RVNC is provided to the Nashville community, he could announce the learning and feedback from the CD Prev program, he could announce the CD sales team progress and programs, he could announce how RVNC is handling early orders for CD and off label therapeutic Daxi….there are tons of communications which could be shared which would build investor confidence and injector confidence and interest! If you know Instagram, providing quality weekly messages is #1 for development of loyal followers!
Foley seems to have this EGO and wants to surprise investors, especially the shorts, with good news rather than put out a constant flow of communications to build trust! Foley only has 1 product to make and sell Daxi and RHA to sell! Foley must communicate to investors, otherwise the shorts will continue to kill the SP! Sales are the magic, and sales grow faster when watered with positive feedback and industry news! As you know, most doctors/injectors are influenced by their doctor friends!
Foley should have a team of consultants who work with each RM and teach their practices how to schedule, price, market Daxi to their patients and the additional profit Daxi will bring rather than continuing to pay himself more! Each converted Botox to Daxi patient is worth at least $500 more profit per year to the practice! Could be $1,000. Foley does not understand the toxin industry and how to communicate!
Sorry, this got a little long 🙄🙄
Recent RVNC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 05/09/2024 08:06:00 PM
- Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia • Business Wire • 05/09/2024 08:05:00 PM
- Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 • Business Wire • 05/02/2024 08:05:00 PM
- Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting • Business Wire • 04/12/2024 12:00:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/27/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:33:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:08:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/05/2024 10:00:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:34:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:33:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:44:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:33:28 PM
- Revance Announces Pricing of $100.0 Million Public Offering of Common Stock • Business Wire • 03/04/2024 02:25:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/04/2024 11:39:11 AM
- Revance Announces Proposed Public Offering of Common Stock • Business Wire • 03/04/2024 11:37:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:36:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:07:18 PM
- Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update • Business Wire • 02/28/2024 09:05:00 PM
- Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024 • Business Wire • 02/21/2024 01:01:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 02/21/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:45:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:28:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 02:39:24 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM